University of Maryland Greenebaum Comprehensive Cancer Center

University of Maryland Greenebaum Comprehensive Cancer Center A National Cancer Institute-designated Comprehensive Cancer Center
Follow UMGCCC on Twitter

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a National Cancer Institute-designated cancer center that brings together expert researchers and clinicians from the University of Maryland School of Medicine and the University of Maryland Medical Center to collaborate on preventing, detecting, and treating cancer.

08/04/2026

Great healthcare starts with great people.

We're proud to celebrate our teams across the University of Maryland Medical System for earning recognition among the nation's and Maryland's best.

University of Maryland Medical Center's University of Maryland Greenebaum Comprehensive Cancer Center is nationally ranked #35 for Cancer and recognized as #2 in Maryland and the Baltimore metro area.

We're proud to have three University of Maryland Medical System hospitals rank among the top five Best Hospitals in Maryland and the Baltimore metro area.

#2 University of Maryland St. Joseph Medical Center
#3 University of Maryland Medical Center
#5 University of Maryland Baltimore Washington Medical Center

Across our system, our hospitals were also recognized as High Performing in 20 adult procedures and conditions, reflecting our shared commitment to safe, high-quality care and better outcomes for our patients.

Congratulations to every team member whose dedication made this recognition possible. Thank you for helping create a better state of care for Maryland.

Early detection can save lives. When lung cancer is found early, treatment is often more effective and outcomes can impr...
08/04/2026

Early detection can save lives. When lung cancer is found early, treatment is often more effective and outcomes can improve. This World Lung Cancer Day, University of Maryland Greenebaum Comprehensive Cancer Center is committed to prevention, screening, and leading-edge patient care for Marylanders and beyond.

See if you meet the screening guidelines and schedule your lung cancer screening today.

https://umms.com/4fGZ7bx

07/29/2026

This is the sound of a new beginning.

After living most of his life with sickle cell disease, Ese Ogbu-Sifo rang the bell at University of Maryland Medical Center to celebrate the completion of a breakthrough gene therapy, one that offers him something he has not always been able to count on: a future.

UMMC is the only hospital in Maryland offering this treatment, and it is built to expand access and close long-standing gaps in care.

Ring that bell, Ese. You have earned it.

A transformative gene therapy program at University of Maryland Medical Center is offering new hope for people living wi...
07/28/2026

A transformative gene therapy program at University of Maryland Medical Center is offering new hope for people living with sickle cell disease. As the only hospital in Maryland certified to provide this FDA-approved treatment, UMMC is helping eligible patients access an innovative therapy designed to address the disease at its source and reduce the painful complications that can impact daily life.

For Ese Sifo, the treatment using his own engineered stem cells has been life-changing. After living with sickle cell pain crises for 45 years, he is now celebrating a new chapter.

"I've been living without the sickle cell pain since then," Sifo said. "I realize that I'm allowed to feel good. I'm allowed to feel like I'm okay. I'm allowed to live without pain."

Co-led by hematologists Dr. Jean Yared and Dr. Jennie Law, UMMC's gene therapy for sickle cell disease program is advancing care for patients across Maryland. While the treatment is not appropriate for everyone, Sifo hopes his experience inspires others to learn more. "I want to ease some of that apprehension and make sure that my story is able to encourage a warrior somewhere as well," he said.

Read more from WBAL-TV 11 Baltimore about what gene therapy could mean for some patients living with sickle cell disease:

The treatment was approved by the FDA in 2023, but UMMC is the only hospital in Maryland certified to do it.

Jessica Ceja has lived with sickle cell disease since she was a toddler. Last month, she became the first patient at a M...
07/07/2026

Jessica Ceja has lived with sickle cell disease since she was a toddler. Last month, she became the first patient at a Maryland hospital to receive Lyfgenia, a gene therapy that uses a patient's own re-engineered stem cells to produce healthy red blood cells. Surrounded by her husband and her care team at the Marlene and Stewart Greenebaum Comprehensive Cancer Center, she began a new chapter.
The road ahead is not over. But it looks different than the one behind.
Swipe through Jessica's story.

06/30/2026

An official website of the State of Maryland.

06/29/2026

The Spotlight on Stomach Cancer symposium is an excellent opportuni...

When Nick Wellnitz turned 45, his primary care doctor urged him to get a colonoscopy to screen for colorectal cancer. He...
06/24/2026

When Nick Wellnitz turned 45, his primary care doctor urged him to get a colonoscopy to screen for colorectal cancer. He’s grateful he didn’t wait. He had a small cancer that was detected so early it could be successfully treated with surgery. No chemotherapy or radiation. A “girl dad” with a very active lifestyle, Nick shudders to think what might have happened had he not taken his doctor’s advice. “Don’t wait until something doesn’t feel right,” he told WBAL-TV 11 Baltimore.

With the increase in younger adults being diagnosed with colorectal cancer, Nick’s gastroenterologist, Dr. Ekta Gupta, Chief of Gastroenterology at University of Maryland Medical Center Midtown Campus, stresses the importance of screening. “It makes a huge difference if you catch any growth or polyp early,” she told WBAL-TV 11 Baltimore. Although there are other options, colonoscopy is the gold standard, she said.

The increasing rate of younger adults diagnosed with colorectal cancer is a phenomenon perplexing medical professionals.

Check out the lights on the University of Maryland Medical Center, illuminated last night in honor of today's  . Featuri...
06/22/2026

Check out the lights on the University of Maryland Medical Center, illuminated last night in honor of today's . Featuring the Downtown Campus and the soon-to-open Stoler Center for Advanced Medicine, the display reflects UMMC's commitment to improving the lives of people living with sickle cell disease.

06/17/2026

This month, Across the Consortium highlights the clinical research contributions Big Ten cancer centers made during the American Society of Clinical Oncology (ASCO) Annual Meeting as well as some unique research programs that are paving the way for future clinical breakthroughs. In addition, we celebrate significant milestones across the Big Ten, from NCI designation renewal to new collaborations that will change the course of clinical care.

But first, we are pleased to annouce registration is now open for the Big Ten CRC Summit on Friday, October 2. See comments for Summit registration link.

And read more at: https://bigtencrc.org/across-the-consortium-june-2026/

Address

22 S. Greene Street
Baltimore, MD
21201

Alerts

Be the first to know and let us send you an email when University of Maryland Greenebaum Comprehensive Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to University of Maryland Greenebaum Comprehensive Cancer Center:

Shortcuts

Featured

Share

Category